If you're stacking BPC-157, TB-500, and CJC-1295, get a schedule showing when to reconstitute each peptide to minimize waste while ensuring maximum potency
Eli Lilly announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety & efficacy of Retatrutide, a first-in-class GIP, GLP-1 & glucagon triple hormone receptor agonist, in adults with obesity or overweight & knee osteoarthritis
Cardiovascular Emerging Evidence Evidence Rating: Emerging (Preliminary animal data) Cardiovascular applications are less studied but intriguing: Cardiac protection Arrhythmia prevention Blood vessel healing Collateral vessel formation Regulatory Status FDA Classification BPC-157 is not approved by the FDA for any medical use in humans
In a podcast episode released in April 2024, Huberman struck a cautionary note, with the Stanford professor using the words cancer, tumor, and risk, more than three dozen times
Many people using Semaglutide report brain fog, which can make daily tasks harder
Semaglutide (Wegovy ) Tablet (Commercial Product by Novo Nordisk) Semaglutide Injectable Description 1-3 Semaglutide, a synthetic glucagon-like peptide-1 receptor agonist (GLP-1 RA), is an incretin mimetic